Skip to main content
RXST filings

Corporate insider profile

Mark Wilterding Filing Activity

Latest reported as Chief Financial Officer of RxSight, Inc. (RXST).

Purchase filings
0
Reported companies
1
Net open-market value
-$54,044.40
Latest transaction
Sep 2, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 2, 2026RxSight, Inc. (RXST)Chief Financial OfficerSale7,765$6.96$54,044